Hemay5259 not checked
Hemay Pharmaceutical PTY. LTD.
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Food influence test: single administration of the drug, multiple dosing trial: administration once daily”In the company’s words, NCT07703904 on ClinicalTrials.gov
- Tested for
- Pharmacokinetics
- Main trialPhase 1
- “Evaluation of the pharmacokinetics of Hemay 5259 sustained-release tablets in healthy human subjects”In the company’s words, NCT07703904 on ClinicalTrials.gov
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Not yet recruiting | 31 Aug 2026 | To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects. |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026